Assessment of micro ribonucleic acids after exercise: Is this the future to detect coronary artery disease at its early stage?

Abstract

Get full access to this article

View all access options for this article.

References

Mozaffarian

Benjamin

et al.

Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation 2015; 131: e29–e322.

Roffi

Patrono

Collet

et al.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationTask Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267–315.

Small

Olson

. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336–342.

Widera

Gupta

Lorenzen

et al.

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011; 51: 872–875.

Malik

Mushtaque

Siddiqui

et al.

Association between coronary artery disease and microRNA: Literature review and clinical perspective. Cureus 2017; 9: e1188–e1188.

Reddy

Shah

Ponde

et al.

Circulating miRNA-33: A potential biomarker in patients with coronary artery disease (CAD). Biomarkers 2018; 19: 1–27.

Chen

Luo

Wei

et al.

Altered plasma miR-144 as a novel biomarker for coronary artery disease. Ann Clin Lab Sci 2018; 48: 440–445.

Hortmann

Walter

Benning

et al.

Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease. Int J Cardiol.. Epub ahead of print 14 August 2018. DOI: 10.1016/j.ijcard.2018.08.031.

Mayr

Müller

Schäfer

et al.

Exercise responsive micro ribonucleic acids identify patients with coronary artery disease. Eur J Prev Cardiol. 2019; 26: 348–355.

10.

Maierthaler

Benner

Hoffmeister

et al.

Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer. Int J Cancer 2016; 140: 176–187.